Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
FENNEC PHARMACEUTICALS INC.
Report date August 31, 2026 · Filed September 01, 2026
Section 16 reporting ended · disclosed 2026-07-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common sharesSEC Table I · non-derivative | Direct | 134,411 |
Reported balance
After 2026-08-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-31 · Grant · Acquired 2,778 · Balance 134,411 F1: Represents shares released from restriction from shares awarded 5/16/2024. |
| Common sharesSEC Table I · non-derivative | Direct | 124,411 |
Reported balance
After 2026-09-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-01 · Sale · Disposed 10,000 · Balance 124,411 F2: Represents shares sold pursuant to a 10b5-1 plan dated September 19, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares released from restriction from shares awarded 5/16/2024.
F2: Represents shares sold pursuant to a 10b5-1 plan dated September 19, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2025 Filed May 19, 2025 20:30 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 16,667 | $6.78 | $113,002.26 |
DisclosureSEC source: 0001415889-25-013642 · form4-05192025_040516.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,254 F2 · security: The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain restricted stock units. Read SEC document |
| May 16, 2025 Filed May 19, 2025 20:30 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantCommon shares | 33,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-013642 · form4-05192025_040516.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,921 F1 · security: Represents shares released from restriction from shares awarded 5-16-2024. Read SEC document |
| May 05, 2025 Filed May 5, 2025 22:23 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 10,000 | $6.31 | $63,100.00 |
DisclosureSEC source: 0001415889-25-012016 · form4-05052025_100512.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,587 F1 · security: Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024. Read SEC document |
| April 30, 2025 Filed May 1, 2025 22:03 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantCommon shares | 2,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011686 · form4-05012025_100501.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,587 F1 · security: Represents release of restriction from shares awarded 3-31-2023 Read SEC document |
| April 04, 2025 Filed Apr 4, 2025 23:29 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 10,000 | $5.25 | $52,500.00 |
DisclosureSEC source: 0001415889-25-010260 · form4-04042025_110426.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,156 F1 · security: Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 21:18 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantCommon shares | 2,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-009399 · form4-04012025_090439.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,156 F1 · security: Represents release of restriction from shares awarded 3-31-2023 Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 22:32 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 10,000 | $6.79 | $67,900.00 |
DisclosureSEC source: 0001415889-25-007264 · form4-03062025_100312.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,725 F1 · security: Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024. Read SEC document |
| February 28, 2025 Filed Feb 28, 2025 23:51 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantCommon shares | 2,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006063 · form4-02282025_110249.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,725 F1 · security: Represents release of restriction from shares awarded 3-31-2023 Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 01:24 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 10,000 | $6.66 | $66,600.00 |
DisclosureSEC source: 0001415889-25-003169 · form4-02062025_010234.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,294 F1 · security: Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 22:50 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantCommon shares | 2,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002787 · form4-02032025_100211.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,294 F1 · security: Represents release of restriction from shares awarded 3-31-2023 Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 22:15 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 7,569 | $6.08 | $46,019.52 |
DisclosureSEC source: 0001415889-25-001014 · form4-01072025_050102.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,863 F2 · security: Shares acquired through the exercise of an option contract with strike price of $2.36 on August 13, 2020. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 22:15 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 2,431 | $6.08 | $14,780.48 |
DisclosureSEC source: 0001415889-25-001014 · form4-01072025_050102.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,432 F1 · security: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 22:46 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantCommon shares | 2,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-000604 · form4-01032025_100101.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,863 F1 · security: Represents release of restriction from shares awarded 3-31-2023 Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 22:00 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | Exercise / conversionStock Options · Derivative | 25,000 | $2.69 Strike: $2.69 | $67,250.00 |
DisclosureSEC source: 0001415889-24-030084 · form4-12232024_051202.xml · derivative · entry 2 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,675,000 Underlying: options · 25,000 shares Expires 2024-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Shares acquired through the exercise of an option contract with strike price of $2.69 and an expiration date of December 31, 2024. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 22:00 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | Exercise / conversionCommon shares | 25,000 | $2.69 | $67,250.00 |
DisclosureSEC source: 0001415889-24-030084 · form4-12232024_051202.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Shares acquired through the exercise of an option contract with strike price of $2.69 and an expiration date of December 31, 2024. Read SEC document |
| December 05, 2024 Filed Dec 5, 2024 21:24 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 796 | $6.04 | $4,807.84 |
DisclosureSEC source: 0001415889-24-028400 · form4-12052024_091215.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,432 F1 · security: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 22:20 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 1,635 | $6.13 | $10,022.55 |
DisclosureSEC source: 0001415889-24-028288 · form4-12042024_101206.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,228 F2 · security: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:20 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantCommon shares | 2,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028288 · form4-12042024_101206.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,863 F1 · security: Represents release of restriction from shares awarded 3-31-2023 Read SEC document |
| November 04, 2024 Filed Nov 4, 2024 22:30 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 2,431 | $4.31 | $10,477.61 |
DisclosureSEC source: 0001415889-24-026039 · form4-11042024_051104.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,432 F2 · security: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023. Read SEC document |
| October 31, 2024 Filed Nov 4, 2024 22:30 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantCommon shares | 2,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-026039 · form4-11042024_051104.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,863 F1 · security: Represents release of restriction from shares awarded 3-31-2023 Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 21:11 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 2,431 | $4.94 | $12,009.14 |
DisclosureSEC source: 0001415889-24-024212 · form4-10012024_091041.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,432 F2 · security: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 21:11 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantCommon shares | 2,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-024212 · form4-10012024_091041.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,863 F1 · security: Represents release of restriction from shares awarded 3-31-2023 Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 22:48 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 2,431 | $5.52 | $13,419.12 |
DisclosureSEC source: 0001415889-24-022813 · form4-09042024_050904.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,432 F2 · security: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023. Read SEC document |
| August 31, 2024 Filed Sep 4, 2024 22:48 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantCommon shares | 2,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-022813 · form4-09042024_050904.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,863 F1 · security: Represents release of restriction from shares awarded 3-31-2023 Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 21:51 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GiftCommon shares | 28,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-022241 · form4-08262024_090823.xml · nonDerivative · entry 3 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,433 F1 · security: This transaction represents a donation of shares of the Issuer's Common Stock to a charity. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 21:51 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GiftCommon shares | 16,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-022241 · form4-08262024_090823.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,805 F1 · security: This transaction represents a donation of shares of the Issuer's Common Stock to a charity. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 21:51 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GiftCommon shares | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-022241 · form4-08262024_090823.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,471 F1 · security: This transaction represents a donation of shares of the Issuer's Common Stock to a charity. Read SEC document |
| August 23, 2024 Filed Aug 27, 2024 21:30 UTC Amendment | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GiftCommon shares | 26,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-022331 · form4a-08272024_050801.xml · nonDerivative · entry 4 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,432 F1 · security: This transaction represents a donation of shares of the Issuer's Common Stock to a charity. F2 · security: This amendment is being filed to correct an administrative error in the Form 4 filed by Mr. Rosty that did not include 26,001 shares donated. Read SEC document |
| August 23, 2024 Filed Aug 27, 2024 21:30 UTC Amendment | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GiftCommon shares | 28,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-022331 · form4a-08272024_050801.xml · nonDerivative · entry 3 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,433 F1 · security: This transaction represents a donation of shares of the Issuer's Common Stock to a charity. Read SEC document |
| August 23, 2024 Filed Aug 27, 2024 21:30 UTC Amendment | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GiftCommon shares | 16,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-022331 · form4a-08272024_050801.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,805 F1 · security: This transaction represents a donation of shares of the Issuer's Common Stock to a charity. Read SEC document |
| August 23, 2024 Filed Aug 27, 2024 21:30 UTC Amendment | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GiftCommon shares | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-022331 · form4a-08272024_050801.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,471 F1 · security: This transaction represents a donation of shares of the Issuer's Common Stock to a charity. Read SEC document |
| August 01, 2024 Filed Aug 1, 2024 20:08 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 2,431 | $6.26 | $15,205.91 |
DisclosureSEC source: 0001415889-24-020512 · form4-08012024_080807.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,471 F2 · security: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023. Read SEC document |
| July 31, 2024 Filed Aug 1, 2024 20:08 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantCommon shares | 2,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-020512 · form4-08012024_080807.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,902 F1 · security: Represents release of restriction from shares awarded 3-31-2023 Read SEC document |
| July 02, 2024 Filed Jul 2, 2024 21:55 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 2,431 | $6.13 | $14,902.03 |
DisclosureSEC source: 0001415889-24-019002 · form4-07022024_090726.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,471 F2 · security: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 21:55 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantCommon shares | 2,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019002 · form4-07022024_090726.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189,902 F1 · security: Represents release of restriction from shares awarded 3-31-2023 Read SEC document |
| June 03, 2024 Filed Jun 3, 2024 21:12 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 2,431 | $6.76 | $16,433.56 |
DisclosureSEC source: 0001415889-24-015177 · form4-06032024_090619.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,471 F2 · security: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023. Read SEC document |
| May 31, 2024 Filed Jun 3, 2024 21:12 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantCommon shares | 2,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015177 · form4-06032024_090619.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189,902 F1 · security: Represents release of restriction from shares awarded 3-31-2023 Read SEC document |
| May 16, 2024 Filed May 21, 2024 21:05 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantRestricted Share Unit · Derivative | 100,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-013982 · form4-05212024_050506.xml · derivative · entry 2 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,855,902 Underlying: Common shares · 100,000 shares Expires 2034-05-16 F3 · security: 1. On May 16, 2024, Rostislav Raykov was awarded restricted share units to receive 100,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan. F4 · derivative.exercise_date: 1/3 of the shares subject to this award shall be released from restriction as of May 16, 2025 (the "Vesting Commencement Date"). 1/24 of the award shall be released from restriction as of the last day of each month following the Vesting Commencement Date. As of April 30, 2027 and thereafter, 100% of the total number of shares subject to this award shall be released. Read SEC document |
| May 16, 2024 Filed May 21, 2024 21:05 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantStock Option · Derivative | 200,000 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001415889-24-013982 · form4-05212024_050506.xml · derivative · entry 1 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,755,902 Underlying: Common shares · 200,000 shares Expires 2034-05-16 F1 · security: On May 16, 2024, Rostislav Raykov was granted incentive stock options to purchase 200,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan. F2 · derivative.exercise_date: 1/3 of the shares subject to this grant shall vest as of May 16, 2025 (the "Vesting Commencement Date"). 1/24 of the grant shall vest as of the last day of each month following the Vesting Commencement Date. As of April 30, 2027 and thereafter, 100% of the total number of shares subject to this grant shall be vested. Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:59 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 2,431 | $9.11 | $22,152.00 |
DisclosureSEC source: 0001415889-24-012016 · form4-05022024_080559.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,471 F2 · security: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023. Read SEC document |
| April 30, 2024 Filed May 2, 2024 20:59 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | GrantCommon shares | 2,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012016 · form4-05022024_080559.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189,902 F1 · security: Represents release of restriction from shares awarded 3-31-2023 Read SEC document |
| April 05, 2024 Filed Apr 5, 2024 20:56 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 44,300 | $10.75 | $476,269.30 |
DisclosureSEC source: 0001415889-24-010435 · form4-04052024_080403.xml · nonDerivative · entry 3 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,471 F3 · security: Represents shares sold pusuant to a 10b5-1 plan dated December 14, 2023. Read SEC document |
| April 04, 2024 Filed Apr 5, 2024 20:56 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 29,700 | $10.89 | $323,528.04 |
DisclosureSEC source: 0001415889-24-010435 · form4-04052024_080403.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 231,771 F2 · security: Represents shares sold pusuant to a 10b5-1 plan dated December 14, 2023. Read SEC document |
| April 04, 2024 Filed Apr 5, 2024 20:56 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 14,583 | $10.89 | $158,871.58 |
DisclosureSEC source: 0001415889-24-010435 · form4-04052024_080403.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 261,471 F1 · security: Represents shares sold pusuant to a 10b5-1 plan dated December 14, 2023. Read SEC document |
| April 03, 2024 Filed Apr 3, 2024 21:37 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 26,000 | $10.78 | $280,261.80 |
DisclosureSEC source: 0001415889-24-010101 · form4-04032024_090409.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 276,054 F2 · security: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023. Read SEC document |
| April 03, 2024 Filed Apr 3, 2024 21:37 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 14,584 | $10.78 | $157,189.27 |
DisclosureSEC source: 0001415889-24-010101 · form4-04032024_090409.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 302,054 F1 · security: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023. Shares sold to satisy tax obligation. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:55 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | PurchaseCommon shares | 29,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010047 · form4-04032024_040401.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,638 F1 · security: Represents release of restriction from shares awarded 3-31-2023. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 21:30 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | Exercise / conversionCommons Shares · Derivative | 8,540 | $1.59 Strike: $1.59 | $13,578.60 |
DisclosureSEC source: 0001415889-23-017015 · form4-12292023_041211.xml · derivative · entry 3 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,784 Underlying: options · 8,540 shares Expires 2024-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Represents options granted on January 24, 2014, with a strike price of $1.59 and an expiration date of January 24, 2024. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 21:30 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon shares | 3,656 | $11.55 | $42,226.80 |
DisclosureSEC source: 0001415889-23-017015 · form4-12292023_041211.xml · nonDerivative · entry 2 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,471 F2 · security: Shares sold to satisfy tax obligation on option exercise. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 21:30 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | Exercise / conversionCommon shares | 8,540 | $1.59 | $13,578.60 |
DisclosureSEC source: 0001415889-23-017015 · form4-12292023_041211.xml · nonDerivative · entry 1 Raykov Rosty · CIK 0001468316 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Shares acquired through the exercise of an option contract with strike price of $1.59 and an expiration date of January 24, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.